111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging.
This document provides general information about somatostatin receptor scintigraphy with (111)In-pentetreotide. This guideline should not be regarded as the only approach to visualise tumours expressing somatostatin receptors or as exclusive of other nuclear medicine procedures useful to obtain comparable results. The aim of this guideline is to assist nuclear medicine physicians in recommending, performing, reporting and interpreting the results of (111)In-pentetreotide scintigraphy.
Bombardieri
Emilio
E
Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.
Ambrosini
Valentina
V
Aktolun
Cumali
C
Baum
Richard P
RP
Bishof-Delaloye
Angelica
A
Del Vecchio
Silvana
S
Maffioli
Lorenzo
L
Mortelmans
Luc
L
Oyen
Wim
W
Pepe
Giovanna
G
Chiti
Arturo
A
D005260:Female; D015902:Gamma Cameras; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007090:Image Interpretation, Computer-Assisted; D009369:Neoplasms / Q000000981:diagnostic imaging* / Q000235:genetics / Q000378:metabolism; D011247:Pregnancy; D011786:Quality Control; D011877:Radionuclide Imaging / Q000295:instrumentation / Q000379:methods*; D017481:Receptors, Somatostatin / Q000378:metabolism; D012107:Research Design; D013004:Somatostatin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics
D017481:Receptors, Somatostatin; D013004:Somatostatin; C081788:pentetreotide
Semin Nucl Med. 2002 Apr;32(2):79-83
11965602
N Engl J Med. 1990 Nov 1;323(18):1246-9
2170840
Ann ICRP. 1998;28(3):1-126
10840563
J Nucl Med. 1999 Oct;40(10):1602-8
10520698
J Clin Oncol. 2008 Feb 20;26(6):963-70
18281671
Neuro Endocrinol Lett. 2007 Jun;28(3):250-1
17627256
J Nucl Med. 1999 Apr;40(4):539-53
10210211
J Nucl Med. 1997 Jun;38(6):853-8
9189129
Eur J Nucl Med. 1993 Aug;20(8):716-31
8404961
Pediatr Blood Cancer. 2008 Mar;50(3):561-6
17387742
Eur J Nucl Med Mol Imaging. 2010 Mar;37(3):662-71
20130859
J Nucl Med. 1995 Apr;36(4):542-9
7699439
Cancer Res. 1995 Dec 1;55(23 Suppl):5801s-5804s
7493349
Semin Nucl Med. 1995 Jul;25(3):251-61
7570044
Ann ICRP. 1991;22(3):1-28, v-xxiv
1845339
Eur J Nucl Med. 1998 Sep;25(9):1284-92
9724378
Q J Nucl Med. 2000 Mar;44(1):42-9
10932600
J Nucl Med. 2001 Jul;42(7):1134-8
11438641
Acad Radiol. 2010 Mar;17(3):291-7
19962915
Ann ICRP. 1987;18(1-4):1-377
3505163
Acta Oncol. 1993;32(7-8):783-6
8305227
Anticancer Res. 1997 May-Jun;17(3B):1583-8
9179198
Ann ICRP. 2008;38(1-2):1-197
19154964
Ann Intern Med. 1996 Jul 1;125(1):26-34
8644985
Clin Cancer Res. 1997 Dec;3(12 Pt 1):2385-91
9815638
Clin Endocrinol (Oxf). 2003 Nov;59(5):565-73
14616879
Eur J Nucl Med. 1998 Jun;25(6):639-58
9618580
Clin Nucl Med. 2009 Dec;34(12):869-73
20139819
Eur Radiol. 1997;7(7):1103-9
9265684
J Nucl Med. 1996 Sep;37(9):1452-6
8790191
Eur J Nucl Med. 1998 Jul;25(7):675-86
9662588
Eur J Nucl Med. 1998 Oct;25(10):1396-403
9818279
Eur J Nucl Med. 1993 Apr;20(4):283-92
8491220
Neuroendocrinology. 2009;90(2):184-9
19713709